Piotr Fularski

ORCID: 0009-0000-7469-7056
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lipoproteins and Cardiovascular Health
  • Diet and metabolism studies
  • Cancer, Lipids, and Metabolism
  • Nutritional Studies and Diet
  • Heart Failure Treatment and Management
  • Cardiovascular Function and Risk Factors
  • Pharmacogenetics and Drug Metabolism
  • Global Health Care Issues
  • Cardiac Imaging and Diagnostics
  • Potassium and Related Disorders
  • Diabetes Treatment and Management
  • Systemic Lupus Erythematosus Research
  • Atherosclerosis and Cardiovascular Diseases
  • Biomarkers in Disease Mechanisms
  • Parathyroid Disorders and Treatments
  • Dialysis and Renal Disease Management
  • Bipolar Disorder and Treatment
  • Coenzyme Q10 studies and effects
  • Ion Transport and Channel Regulation
  • Lipid metabolism and disorders
  • Coronary Interventions and Diagnostics
  • Antioxidant Activity and Oxidative Stress
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Chronic Kidney Disease and Diabetes
  • Gut microbiota and health

Medical University of Lodz
2023-2024

Diabetic cardiomyopathy (DCM) is the development of myocardial dysfunction in patients with diabetes despite absence comorbidities such as hypertension, atherosclerosis or valvular defect. The cardiovascular complications poorly controlled are very well illustrated by U.K. Prospective Diabetes Study (UKPDS), which showed a clear association between increasing levels glycated hemoglobin and heart failure (HF). incidence HF projected to increase significantly, why its proper diagnosis...

10.3390/biomedicines12040765 article EN cc-by Biomedicines 2024-03-29

Atherosclerotic cardiovascular disease (ASCVD) stands as the leading cause of mortality worldwide. At its core lies a progressive process atherosclerosis, influenced by multiple factors. Among them, lifestyle-related factors are highlighted, with inadequate diet being one foremost, alongside such cigarette smoking, low physical activity, and sleep deprivation. Another substantial group risk comprises comorbidities. Amongst others, conditions hypertension, diabetes mellitus (DM), chronic...

10.3390/ijms25105212 article EN International Journal of Molecular Sciences 2024-05-10

Familial hypercholesterolemia (FH) is a genetic disorder primarily transmitted in an autosomal-dominant manner. We distinguish two main forms of FH, which differ the severity disease, namely homozygous familial (HoFH) and heterozygous (HeFH). The characteristic feature this disease high concentration low-density lipoprotein cholesterol (LDL-C) blood. However, level may significantly vary between mentioned types it decidedly higher HoFH. A chronically elevated LDL-C plasma leads to occurrence...

10.3390/ijms25031637 article EN International Journal of Molecular Sciences 2024-01-29
Coming Soon ...